We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder


Department of Health and Social Care written question – answered on 20th February 2019.

Alert me about debates like this

Photo of Sammy Wilson Sammy Wilson Shadow DUP Spokesperson (Treasury), Shadow DUP Spokesperson (Work and Pensions), Shadow DUP Spokesperson (Brexit)

To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of using a Crown licence obtain the drug Orkambi at an affordable price.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

It is right that patients should have access to cost-effective, innovative medicines at a price that is affordable to the National Health Service. As explained in the adjournment debate on 4 February, the Government is clear Crown Use is not a quick or easy solution but it is important we consider all options.

The manufacturer, Vertex, needs to agree the very generous offer that has been made so that patients who need Orkambi are able to access it on the NHS. This is in the best interests of patients.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.